Clinical Trial Update: A Bioequivalence Study of Capecitabine Tablets [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Capecitabine tablets completed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. The study examined a Capecitabine formulation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Metastatic Breast Cancer or Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED